Xtant Medical Holdings (XTNT) Receivables (2010 - 2025)

Xtant Medical Holdings (XTNT) has reported Receivables for 16 consecutive years, with $17.8 million the latest figure, recorded in Q4 2025.

• On a quarterly basis, Receivables fell 19.44% year-over-year to $17.8 million in Q4 2025; TTM through Dec 2025 was $17.8 million, a 19.44% decrease from a year earlier, with the FY2025 full-year figure at $17.8 million, down 19.44% from the prior year.
• Receivables was $17.8 million for Q4 2025 at Xtant Medical Holdings, down from $25.5 million in the prior quarter.
• Over five years, Receivables peaked at $27.0 million in Q2 2025 and troughed at $6.3 million in Q3 2021.
• A 5-year average of $15.5 million and a median of $15.8 million in 2023 frame the typical range for Receivables.
• Across the five-year window, Receivables dropped 27.88% in 2021 and jumped 99.94% in 2023, its largest moves.
• Over 5 years, Receivables stood at $7.2 million in 2021, then jumped by 51.71% to $10.9 million in 2022, then jumped by 99.94% to $21.7 million in 2023, then gained by 1.84% to $22.1 million in 2024, then slipped by 19.44% to $17.8 million in 2025.
• The last three Receivables figures came in at $17.8 million (Q4 2025), $25.5 million (Q3 2025), and $27.0 million (Q2 2025), per Business Quant data.